Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K111004
    Date Cleared
    2012-05-29

    (414 days)

    Product Code
    Regulation Number
    870.1290
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K102168, K080415

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Hansen Medical Vascular Catheter Control System, Hansen Catheter and accessory components are intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.

    Device Description

    The Hansen Medical Magellan Robotic System and NorthStar Robotic Catheter and Accessory Components are designed to facilitate remote navigation to anatomical targets in the peripheral vasculature. Subsequent to navigation, the system provides a conduit for manual placement of therapeutic devices. The Magellan Robotic System's operating principles are similar to those of the Sensei X Robotic Catheter System. The fundamental concept of the robotic system is based on a master/slave control system that enables and visualizes positioning of a steerable catheter tip at a desired point inside the vasculature, while enabling a physician to remain seated and away from the x-ray radiation source.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the Hansen Medical Magellan™ Robotic System, NorthStar™ Robotic Catheter, and Accessory Components, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided text does not explicitly state numerical acceptance criteria in a table format with corresponding performance results. However, it describes the types of tests conducted and concludes that the device successfully met established specifications and did not raise new questions of safety or effectiveness.

    Therefore, the table below reflects what was stated as satisfactorily completed or demonstrated success rather than explicit numerical acceptance criteria.

    Test TypeAcceptance/Performance Statement
    Bench/Preclinical Testing
    Visual and Dimensional VerificationSuccessfully executed; meet established specifications.
    Tensile TestingSuccessfully executed; meet established specifications.
    Articulation Force TestingSuccessfully executed; meet established specifications.
    Articulation Angle TestingSuccessfully executed; meet established specifications.
    Guidewire insertion forceSuccessfully executed; meet established specifications.
    Tracking in simulated anatomySuccessfully executed; meet established specifications.
    Device Leak TestingSuccessfully executed; meet established specifications.
    Device Bending Stiffness TestingSuccessfully executed; meet established specifications.
    System Verification TestingSuccessfully executed; meet established specifications.
    Electromagnetic Test (EMC)Successfully executed; meet established specifications.
    Biocompatibility TestingNorthStar Robotic Catheter successfully passed all tests (Cytotoxicity, Sensitization, Maximization, Acute System Toxicity, Intracutaneous Reactivity/Irritation, Complement Activation, Thrombogenicity, Pyrogenicity, Hemolysis, In Vitro Platelet Aggregation, Prothrombin time assay, Partial Thromboplastin time assay).
    Package TestingSuccessfully executed; meet established specifications.
    Device Fatigue TestingSuccessfully executed; meet established specifications.
    Shipping/Distribution TestingSuccessfully executed; meet established specifications.
    Sterility TestingValidated sterility assurance level (SAL) is 10⁻⁶ for NorthStar Robotic Catheter (EtO) and Accessory Components (gamma irradiation).
    Shelf Life and Life Cycle TestingSuccessfully executed; meet established specifications.
    Coating Particulate TestingSuccessfully executed; meet established specifications.
    Device Evaluation in Porcine modelSuccessfully executed; meet established specifications.
    System Electrical (IEC) TestingSuccessfully executed; meet established specifications.
    Software Validation TestSuccessfully executed; meet established specifications.
    Animal Studies (GLP)
    5-day survival studySystem functionality and performance met system design requirements in vivo. Resulted in fewer and less severe vascular injuries compared to manual control.
    30-day survival studySystem functionality and performance met system design requirements in vivo. Resulted in fewer and less severe vascular injuries compared to manual control.
    Clinical Study
    Navigation effectivenessRobotic navigation successfully cannulated 20 of 20 target vessels (100% success rate).
    Angiographic assessmentSelective angiography of the target vessel completed in 20 cases.
    Robotic guidance of catheter/guidewireSystem able to remotely navigate a robotically deflectable catheter and guide-wire into the target vessel in all 20 cases. NorthStar Robotic Catheter robotically navigated to targeted lesion in all 20 cases.
    SafetyNo device-related adverse events. All patients free from access site complications at discharge.

    2. Sample Size Used for the Test Set and Data Provenance

    The clinical study involved:

    • Sample Size: 20 procedures (15 enrolled subjects).
    • Data Provenance: The study was a "prospective, single center" study. The country of origin is not explicitly stated, but given the applicant's US address and the FDA submission, it is highly likely to be a US-based study. It was prospective.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    The provided text describes a clinical study focused on the device's performance in navigating and delivering therapeutic devices rather than an image-based diagnostic task requiring ground truth established by experts interpreting images. Therefore, this information is not applicable in the context of the provided text. The "ground truth" for the clinical study was the actual successful cannulation of vessels and completion of procedures, along with safety outcomes.

    4. Adjudication Method for the Test Set

    As this was a performance study of a robotic system in a clinical setting (not an image interpretation study), an "adjudication method" in the sense of reconciling differing expert opinions on a diagnosis is not applicable. The primary outcome measures (successful cannulation, completion of angiography, navigation to lesion, absence of adverse events) would have been observed and recorded by the operating physicians and study staff according to the study protocol.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    There was no MRMC comparative effectiveness study described in the provided text. The clinical study was a single-arm study evaluating the device's performance, not comparing human readers with and without AI assistance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    The provided text describes the device as a "master/slave control system" where the physician inputs commands to control the robotic catheter. This inherently describes a human-in-the-loop system. Therefore, a standalone (algorithm only) performance, in the sense of a fully autonomous AI system making decisions without human input, was not performed nor is it relevant to this device's intended use or design.

    7. The Type of Ground Truth Used

    • Bench/Preclinical Testing: Engineering specifications, ISO standards, and established biological/material science outcomes (e.g., successful visual verification, tensile strength values, biocompatibility panel results, sterility levels, tracking pathways in simulated anatomy).
    • Animal Studies: Observed in-vivo functionality, performance against system design requirements, comparison of vascular injury rates (fewer and less severe injuries compared to manual control).
    • Clinical Study: Direct observation of successful robotic navigation (cannulation, guidance to target), successful completion of angiography, absence of device-related adverse events, and ultrasound confirmation of no access site complications. This is essentially outcomes data and direct procedural success.

    8. The Sample Size for the Training Set

    The provided text describes the Magellan Robotic System as having operating principles "nearly identical" to the predicate Sensei X Robotic Catheter System (K102168). It is a robotic control system for a catheter, not a machine learning or AI algorithm that requires a "training set" in the conventional sense used for diagnostic imaging AI. Therefore, the concept of a "training set" with a specific sample size for a machine learning model is not applicable to this device as described. The system's "training" would have been through engineering design, software development, and iterative testing/refinement.

    9. How the Ground Truth for the Training Set Was Established

    As explained above, the concept of a "training set" for a machine learning model is not applicable here. The "ground truth" for the development of such a robotic system would be its adherence to engineering specifications, safety standards, and functional requirements established through design, simulation, and rigorous testing against known physical and mechanical principles.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1